The coronavirus disease 2019 (COVID-19) pandemic has shattered the processes meticulously developed over years by which physicians delivered quality care for patients with cirrhosis. COVID-19 has exposed deep flaws in the structural and process measures developed to follow patients, evaluate disease status and response to therapy, and screen for complications, each of which depends upon frequent physical patient-physician interaction.